Browse Studies — Arctuva

Observational

NON-INVASIVE BRAIN STIMULATION FOR MEMORY LOSS IN EARLY ALZHEIMER'S DISEASE

The goal of this clinical trial is to learn if repetitive transcranial magnetic stimulation (rTMS), a non-invasive form of brain stimulation, can improve short…

Alzheimer s DiseaseMild Cognitive Impairment (MCI) Due to Alzheimer's DiseaseMild Dementia

Estimated

~$10 – $7,500

Chi-Ying (Roy) LinNCT07667478

Phase 2

Safety Assessment of Leronlimab and Its Effect on Neuroinflammation Targets in Alzheimer's Disease

The present study will administer the drug leronlimab to 20 participants who are above 50 years old with Alzheimer's disease (AD) or mild cognitive impairment …

Mild Cognitive Impairment (MCI) Due to Alzheimer's DiseaseAlzheimer's Disease

Estimated

~$10 – $6,250

Weill Medical College of Cornell UniversityNCT07553338

Observational

Mechanisms of Mindfulness for Cognition in Early-Stage Alzheimer's Disease

The goal of this clinical trial is to learn if mindfulness meditation can improve outcomes in older adults with and without cognitive impairment. The main ques…

Mild Cognitive Impairment (MCI)Mild Cognitive Impairment (MCI) Due to Alzheimer's DiseaseTBI (Traumatic Brain Injury)+3 more

Estimated

~$10 – $7,500

VA Boston Healthcare SystemNCT06792877

Prospective Study on Anti-Amyloid-β Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease Coverage of Evidence Development (The Anti-Aβ mAb CED Study)

The Anti-Aβ mAb CED Study is a prospective, longitudinal coverage with evidence development (CED) study using clinical data, patient assessments, and administr…

Mild Alzheimer's DiseaseMild Cognitive Impairment (MCI) Due to Alzheimer's Disease

Estimated

~$10 – $1,050

Centers for Medicare and Medicaid Services/ Coverage and Analysis GroupNCT06058234